BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38519054)

  • 1. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.
    Cornel AM; van der Sman L; van Dinter JT; Arrabito M; Dunnebach E; van Hoesel M; Kluiver TA; Lopes AP; Dautzenberg NMM; Dekker L; van Rijn JM; van den Beemt DAMH; Buhl JL; du Chatinier A; Barneh F; Lu Y; Lo Nigro L; Krippner-Heidenreich A; Sebestyén Z; Kuball J; Hulleman E; Drost J; van Heesch S; Heidenreich OT; Peng WC; Nierkens S
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells.
    Jin H; Ladd NA; Peev AM; Swarbrick GM; Cansler M; Null M; Boughter CT; McMurtrey C; Nilsen A; Dobos KM; Hildebrand WH; Lewinsohn DA; Adams EJ; Lewinsohn DM; Harriff MJ
    Sci Rep; 2022 Dec; 12(1):22539. PubMed ID: 36581641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
    Crowther MD; Dolton G; Legut M; Caillaud ME; Lloyd A; Attaf M; Galloway SAE; Rius C; Farrell CP; Szomolay B; Ager A; Parker AL; Fuller A; Donia M; McCluskey J; Rossjohn J; Svane IM; Phillips JD; Sewell AK
    Nat Immunol; 2020 Feb; 21(2):178-185. PubMed ID: 31959982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR1-restricted T cells: the new dawn of cancer immunotherapy.
    Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
    Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G
    Front Immunol; 2020; 11():751. PubMed ID: 32411144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
    Lepore M; Lewinsohn DA; Lewinsohn DM
    Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionally diverse human T cells recognize non-microbial antigens presented by MR1.
    Lepore M; Kalinichenko A; Calogero S; Kumar P; Paleja B; Schmaler M; Narang V; Zolezzi F; Poidinger M; Mori L; De Libero G
    Elife; 2017 May; 6():. PubMed ID: 28518056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
    Corbett AJ; Awad W; Wang H; Chen Z
    Front Immunol; 2020; 11():1961. PubMed ID: 32973800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the antigen-presenting molecule MR1 by a Vδ3
    Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.
    McWilliam HEG; Villadangos JA
    Nat Rev Immunol; 2024 Mar; 24(3):178-192. PubMed ID: 37773272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease.
    Crowther MD; Sewell AK
    Curr Opin Immunol; 2021 Apr; 69():10-17. PubMed ID: 33434741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR1, an immunological periscope of cellular metabolism.
    Chancellor A; Vacchini A; De Libero G
    Int Immunol; 2022 Feb; 34(3):141-147. PubMed ID: 34718585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
    Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
    Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans.
    Swarbrick GM; Gela A; Cansler ME; Null MD; Duncan RB; Nemes E; Shey M; Nsereko M; Mayanja-Kizza H; Kiguli S; Koh J; Hanekom WA; Hatherill M; Lancioni C; Lewinsohn DM; Scriba TJ; Lewinsohn DA
    Front Immunol; 2020; 11():556695. PubMed ID: 33042140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.
    Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I
    J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antigenic requirements by diverse MR1-restricted T cells.
    Seneviratna R; Redmond SJ; McWilliam HE; Reantragoon R; Villadangos JA; McCluskey J; Godfrey DI; Gherardin NA
    Immunol Cell Biol; 2022 Feb; 100(2):112-126. PubMed ID: 34940995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covering All the Bases: Complementary MR1 Antigen Presentation Pathways Sample Diverse Antigens and Intracellular Compartments.
    Kulicke C; Karamooz E; Lewinsohn D; Harriff M
    Front Immunol; 2020; 11():2034. PubMed ID: 32983150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation.
    Kulicke CA; De Zan E; Hein Z; Gonzalez-Lopez C; Ghanwat S; Veerapen N; Besra GS; Klenerman P; Christianson JC; Springer S; Nijman SM; Cerundolo V; Salio M
    J Biol Chem; 2022 Feb; 298(2):101542. PubMed ID: 34968463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
    Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.